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Presidential Address 961 For everything there is a season
Tirone E. David, MD, Toronto, Ontario, Canada
Editorial 966 Optimizing cardiac cell therapy: From processing to delivery Œ
Gilbert H. L. Tang, MD, Shafie Fazel, MD, MSc, Richard D. Weisel, MD,
Subodh Verma, MD, PhD, and Ren-Ke Li, MD, PhD, Toronto, Ontario, Canada
General Thoracic
Surgery
(GTS)
969 The impact of stage and cell type on the prognosis of pulmonary
neuroendocrine tumors
Eric Lim, MRCS, Yoong K. Yap, MRCS, Bianca L. De Stavola, PhD,
Andrew G. Nicholson, MRCPath, and Peter Goldstraw, FRCS, London, United Kingdom
To clarify the influence of stage and cell type on prognosis of pulmonary neuroendocrine
tumors, we examined a historic cohort over a 23-year period. Although there was a close
association between increasing stage and malignant cell type, only age and cell type remained
as independent predictors of mortality.
973 Progress toward an ambulatory pump-lung
Zhongjun J. Wu, PhD, Mark Gartner, MS, Kenneth N. Litwak, PhD, DVM, and
Bartley P. Griffith, MD, Baltimore, Md, Pittsburgh, Pa, and Louisville, Ky
An integrated pump-lung device–based active mixing oxygenation process is presented. The
functional and biocompatibility performances were evaluated both in vitro and in vivo. The
device demonstrated extremely high gas exchange efficiency. The ability to eliminate concerns
about the native right ventricle’s ability to power blood through the lung is a major advantage.
979 The significance of estrogen receptor  in 301 surgically treated non–small
cell lung cancers
Chen-Tu Wu, MD, Yih-Leong Chang, MD, Jin-Yuan Shih, MD, PhD,
and Yung-Chie Lee, MD, PhD, Taipei, Taiwan
Three hundred one cases of non–small cell lung carcinoma were examined for estrogen
receptor (ER)  and ER expression by means of immunohistochemistry. Our results show for
the first time that ER overexpression can be used as a prognostic indicator in patients with
surgically resected stage II and III non–small cell lung carcinomas.
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987 Intercostal muscle flap reduces the pain of thoracotomy: A prospective
randomized trial
Robert James Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD, Bhavik Patel, BS,
and Alfred A. Bartolucci, PhD, Birmingham, Ala
A prospective randomized study on 114 patients found that an intercostal muscle flap harvested
before chest retraction decreases the pain of thoracotomy at 1, 2, 3, 4, 8, and 12 weeks,
improves spirometry, and leads to less narcotic use and to quicker return to normal activities.
Surgery for Acquired
Cardiovascular Disease
(ACD)
994 Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical
performance over 20 years
W. R. Eric Jamieson, MD, Lawrence H. Burr, MD, Robert T. Miyagishima, MD,
Eva Germann, MSc, Joan S. MacNab, Elizabeth Stanford, BScN, Florence Chan,
Michael T. Janusz, MD, and Hilton Ling, MD, Vancouver, British Columbia, Canada
Experience with the Carpentier-Edwards supra-annular aortic porcine bioprosthesis was
evaluated longitudinally over 20 years. From 1981 through 1999, 1823 patients (mean age,
68.9  10.9 years; range, 19-89 years) underwent 1847 procedures. Clinical performance was
evaluated by actuarial and actual analysis. Hemodynamic performance was evaluated by
echocardiographic/Doppler assessment. Morphology of structural failure was evaluated from
pathologic examinations.
1001 Correlation of autologous skeletal myoblast survival with changes in left
ventricular remodeling in dilated ischemic heart failure Œ
Patrick I. McConnell, MD, Carlos L. del Rio, BS, Douglas B. Jacoby, PhD,
Martina Pavlicova, PhD, Pawel Kwiatkowski, MD, Agatha Zawadzka, MS,
Jonathan H. Dinsmore, PhD, Louis Astra, MD, Sheik Wisel, PhD, and Robert E. Michler, MD,
Columbus, Ohio, and Charlestown, Mass
The benefits of autologous skeletal myoblast (ASM) transplantation on cardiac function in
ischemic heart failure (HF) with severe ventricular dilation free from concomitant
revascularization are unknown. In sheep with ischemic HF, ASM injection attenuated left
ventricular dilatation and correlated with an estimate of ASM survival.
1010 Aortic root replacement with a novel decellularized cryopreserved aortic
homograft: Postoperative immunoreactivity and early results
Kenton J. Zehr, MD, Marineh Yagubyan, MD, Heidi M. Connolly, MD, Susan M. Nelson, LPN,
and Hartzell V. Schaff, MD, Rochester, Minn
Twenty-two patients underwent aortic root replacement with CryoLife SynerGraft aortic valve
conduit homografts. At 1 year, 95% of patients had negative PRA results, and mean aortic
valve gradient was 11  7 mm Hg. Decellularization successfully removed antigens without
sacrificing the low transvalvular gradients seen with standard cryopreserved homografts.
Table of Contents (continued)
(continued on page 12A)
10A The Journal of Thoracic and Cardiovascular Surgery ● October 2005
ED
ITO
RIA
L
G
TS
A
CD
CH
D
ET
CSP
TX
1016 In vitro evaluation of aortic valve prosthesis in a novel valved conduit with
pseudosinuses of Valsalva
Ruggero De Paulis, MD, Christoph Schmitz, Dr-Ing, Raffaele Scaffa, MD, Paolo Nardi, MD,
Luigi Chiariello, MD, and Helmut Reul, Dr-Ing, Rome, Italy, and Aachen, Germany
A new Dacron conduit with a sculpted sinus was tested in vitro in a composite aortic root
replacement configuration and compared with a standard straight graft. The hydrodynamic
properties of mechanical and biologic prosthetic aortic valves were not influenced by the
anatomic configuration of the newly reconstructed aortic root.
1022 Quality of life outcomes after coronary artery bypass graft surgery:
Relationship to neuropsychologic deficit
Everard W. Thornton, PhD, Christina Groom, PhD, Brian M. Fabri, MD,
Mark A. Fox, MB, BS, Claire Hallas, PhD, and Mark Jackson, PhD, Liverpool and Middlesex,
United Kingdom
Health-related quality of life (HRQoL), mood, and cognitive changes were documented after
CABG surgery. All dimensions of HRQoL improved, but changes were less significant for
emotional and social aspects than physical dimensions. Less favorable outcomes were reported
in proxy ratings. Proxy, but not self-reported HRQoL, outcomes were related to cognitive
deficits.
1028 Early and midterm patency of the proximal anastomoses of saphenous vein
grafts made with a Symmetry Aortic Connector System
Hideki Kitamura, MD, Hitoshi Okabayashi, PhD, Michiya Hanyu, PhD, Yoshiharu Soga, PhD,
Takuya Nomoto, PhD, Hiroyuki Johno, MD, Jota Nakano, MD, Takehiko Matsuo, MD,
Masashi Kai, MD, and Eitaro Umehara, MD, Fukuoka, Japan
OPCAB was performed for proximal saphenous vein graft anastomoses with the Symmetry
Aortic Connector System. Once surgical errors were ruled out, the 1-year patency rate was
favorable. Poor left ventricular function and intraoperative low graft flow were risk factors for
midterm graft occlusion.
1032 Left ventricular volume and function after endoventricular patch plasty for
dyskinetic anteroapical left ventricular aneurysm in sheep
Peng Zhang, MD, PhD, Julius M. Guccione, PhD, Susan I. Nicholas, MD,
Joseph C. Walker, PhD, Philip C. Crawford, CCP, Amin Shamal, MD, David A. Saloner, PhD,
Arthur W. Wallace, MD, PhD, and Mark B. Ratcliffe, MD, San Francisco, Calif
The Dor procedure was performed on 6 sheep with anteroapical aneurysm. The Dor procedure
significantly reduces LV volume. Unlike linear repair, LV volume changes seem stable.
Ejection fraction is improved, and LV function (stroke volume and the Starling relationship) is
maintained.
1039 Endovascular repair of aneurysm after previous surgical coarctation repair
Michael Gawenda, MD, Marko Aleksic, MD, Jörg Heckenkamp, MD, Karsten Kru¨ger, MD, and
Jan Brunkwall, MD, PhD, Cologne, Germany
False aneurysms are life-threatening complications of coarctation repair. The minimal approach
of endoluminal stent grafting seems to be a promising alternative to the redo operation, which
has high mortality and morbidity.
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1044 In vitro hydrodynamics, cusp-bending deformation, and root distensibility
for different types of aortic valve–sparing operations: Remodeling, sinus
prosthesis, and reimplantation
Armin Erasmi, MD, Hans-H. Sievers, MD, Michael Scharfschwerdt, Thorsten Eckel, and
Martin Misfeld, MD, PhD, Luebeck, Germany
Different aortic valve–sparing techniques are studied in vitro. The more the physiologic
distensibility of the aortic root is restricted by noncompliant prosthetic material, the more the
native root dynamics are impaired. The remodeling techniques provided valve dynamics closest
to those of the native root.
Surgery for Congenital
Heart Disease
(CHD)
1050 Does a bidirectional Glenn shunt improve the oxygenation of right ventricle–
dependent coronary circulation in pulmonary atresia with intact ventricular
septum?
Kagami Miyaji, MD, Arata Murakami, MD, Tai-ichi Takasaki, MD, Kuniyoshi Ohara, MD,
Shinichi Takamoto, MD, and Hirokuni Yoshimura, MD, Sagamihara and Tokyo, Japan
Seven patients with pulmonary atresia with intact ventricular septum and right
ventricle–dependent coronary circulation underwent bidirectional Glenn shunt at a mean age of
18 months. Oxygen saturation increased significantly, and all subsequently underwent Fontan
procedures with excellent results. Early bidirectional Glenn shunt could prevent progression of
myocardial ischemia in such cases.
1054 Protein oxidation injury occurs during pediatric cardiopulmonary bypass
Meredith L. Sheil, MBBS, FRACP, Catherine Luxford, PhD, Michael J. Davies, DPhil,
Jennifer K. Peat, PhD, Graham Nunn, MBBS, FACS, and
David S. Celermajer, MBBS, FRACP, PhD, Sydney, Australia
Proteins, the principal effectors of biological work, are susceptible to oxidation injury. This
study demonstrates that structural injury to proteins occurs as a result of oxidation during
pediatric CPB, particularly in cyanotic children, and may be associated with adverse
postoperative outcomes.
1062 Distribution of cardiac output and oxygen delivery in an acute animal model
of single-ventricle physiology
Marco Ricci, MD, Pierluca Lombardi, MD, Alvaro Galindo, MD, Amelia Vasquez,
Jennifer Zuccarelli, and Eliot Rosenkranz, MD, Miami, Fla
Single-ventricle physiology might restrict oxygen availability to systemic organs. By using a
piglet model of univentricular physiology, we established the pattern of cardiac output
distribution and determined that this physiology can restrict oxygen availability to the
gastrointestinal system, liver, kidneys, and partly to the brain.
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1071 Pulmonary atresia with intact ventricular septum: Predictors of early and
medium-term outcome in a population-based study
Piers E. F. Daubeney, MRCP, D. Wang, PhD, D. J. Delany, FRCR, B. R. Keeton, FRCP,
R. H. Anderson, MD, Z. Slavik, MD, M. Flather, MD, and S. A. Webber, MRCP, for the UK
and Ireland Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum, London
and Southampton, United Kingdom, and Pittsburgh, Pa
Pulmonary atresia with intact ventricular septum (PAIVS) is a disease with often poor outcome.
The UK and Ireland Collaborative Study of PAIVS is a population-based multicenter study of
all patients with this disease born from 1991 through 1995. One hundred eighty-three patients
were enrolled. Five-year survival was 64%, and risk factors for death comprised low birth
weight, unipartite right ventricular morphology, and the presence of a dilated right ventricle.
1079 Upregulation of hypoxia inducible factor is associated with attenuation of
neuronal injury in neonatal piglets undergoing deep hypothermic circulatory
arrest
Faraz Kerendi, MD, Michael E. Halkos, MD, Hajime Kin, MD, Joel S. Corvera, MD,
Daniel J. Brat, MD, PhD, Mary B. Wagner, PhD, Jakob Vinten-Johansen, PhD,
Zhi-Qing Zhao, PhD, Joseph M. Forbess, MD, Kirk R. Kanter, MD, Mary E. Kelley, PhD, and
Paul M. Kirshbom, MD, Atlanta, Ga
Deep hypothermic circulatory arrest (DHCA) causes neurological injury. Hypoxia inducible
factor (HIF-1) is an adaptive transcription factor mediated in part by upregulation of
erythropoietin (EPO). This study tests the hypothesis that upregulation of HIF-1 and EPO by
preconditioning with hypoxia, deferoxamine, or cobalt chloride is neuroprotective after
cardiopulmonary bypass and prolonged DHCA.
1086 Tracheostomy in infants and children after cardiothoracic surgery:
Indications, associated risk factors, and timing
Aparna Hoskote, MD, MRCP, Gordon Cohen, MD, PhD, Allan Goldman, MRCP, and
Lara Shekerdemian, MD, MRCP, FRACP, London, United Kingdom
Thirty-seven children underwent tracheostomy for prolonged respiratory support after
cardiothoracic surgery. Twenty-two children survived to hospital discharge; 15 were
decannulated. Tracheostomy can be carried out safely and without major risk in children early
after cardiothoracic surgery. The presence of identifiable risk factors should alert clinicians to
early consideration of tracheostomy.
1094 Systemic venous oxygen saturation after the Norwood procedure and
childhood neurodevelopmental outcome
George M. Hoffman, MD, Kathleen A. Mussatto, BSN, Cheryl L. Brosig, PhD,
Nancy S. Ghanayem, MD, Ndidiamaka Musa, MD, Raymond T. Fedderly, MD,
Robert D. B. Jaquiss, MD, and James S. Tweddell, MD, Milwaukee, Wis
Patients who had decreased systemic venous oxygen saturation as neonates after the Norwood
procedure had reduced childhood neurodevelopmental performance at age 4 years.
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1101 Chronic hypoxemia increases myocardial cytochrome oxidase
David A. Piel, BS, Azeem R. Khan, MD, Robert Waibel, BS, Mariusz Birbach, MD,
Meryl S. Cohen, MD, Thomas L. Spray, MD, Clifford S. Deutschman, MD,
J. William Gaynor, MD, and Richard J. Levy, MD, Philadelphia, Pa
Although children with cyanotic heart disease have higher perioperative morbidity and
mortality compared with acyanotic patients, there is no difference in cardiac performance
preoperatively. Here we evaluate the mitochondrial gene expression and kinetic activity of
myocardial cytochrome oxidase as one possible cellular adaptive mechanism that might
preserve organ function during chronic hypoxemia.
Evolving Technology
(ET)
1107 Ventricular constraint in dilated cardiomyopathy: A new, compliant textile
mesh exerts prophylactic and therapeutic properties
P. Feindt, MD, U. Boeken, MD, J. D. Schipke, PhD, J. Litmathe, MD, N. Zimmermann, MD,
and E. Gams, MD, Duesseldorf, Germany
The effects of a new polyvinylidene fluoride mesh on the development-reduction of pacing-
induced dilated cardiomyopathy were investigated in 16 minipigs. The passive-elastic constraint
prevented deterioration and also exerted reverse remodeling to some extent. Ventricular
constraint seemingly is a prophylactic and therapeutic option in cardiac insufficiency caused by
ventricular dilation.
1114 Persistence of marrow stromal cells implanted into acutely infarcted
myocardium: Observations in a xenotransplant model
Derek J. MacDonald, MD, Jun Luo, MD, Takayuki Saito, MD, PhD, Minh Duong, BSc,
Pierre-Luc Bernier, MD, Ray C. J. Chiu, MD, PhD, and Dominique Shum-Tim, MD, Montreal,
Quebec, Canada
Xenogeneic bone marrow stromal cells implanted into acutely ischemic myocardium after
coronary artery ligation were immunologically tolerated, survived, and differentiated, resulting
in a cardiac chimera with improved LV function. This unique immunologic tolerance suggests
the feasibility of using these cells as universal donor cells.
Cardiopulmonary
Support and Physiology
(CSP)
1122 Long-term support of 9 patients with the DeBakey VAD for more than 200
days
Markus J. Wilhelm, MD, Dieter Hammel, MD, Christof Schmid, MD, Andreas Rhode, MS,
Timo Kaan, MS, Markus Rothenburger, MD, Jörg Stypmann, MD, Michael Schäfers, MD,
Christoph Schmidt, MD, Hideo A. Baba, MD, and Hans H. Scheld, MD, Muenster, Germany
Treatment of 9 patients with the DeBakey VAD for a total of 7.8 years (mean duration, 314 
75 days) demonstrated its capability of long-term support. The continuous-flow device restored
and maintained normal organ function. It is associated with good patient comfort, no
perioperative bleeding events, and a low incidence of infection.
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1130 Perivascular adipose tissue modulates vascular function in the human
internal thoracic artery
Yu-Jing Gao, MD, PhD, Zhao-hua Zeng, MD, Kevin Teoh, MD, Arya M. Sharma, MD, PhD,
Labib Abouzahr, MD, Irene Cybulsky, MD, Andre Lamy, MD, Lloyd Semelhago, MD, and
Robert M. K. W. Lee, PhD, Hamilton, Ontario, Canada
The presence of perivascular adipose tissue attenuated the contraction of human ITAs to U
46619 and to phenylephrine, mainly because perivascular adipose tissue releases a transferable
relaxing factor that dilates the artery through the activation of calcium-dependent potassium
channels. This might have clinical relevance because perivascular adipose tissue is usually
removed during CABG.
1137 Reporting and classification of patient safety events in a cardiothoracic
intensive care unit and cardiothoracic postoperative care unit
Patricia A. Nast, BSN, Michael Avidan, MD, Carolyn B. Harris, MPH,
Melissa J. Krauss, MPH, Eric Jacobsohn, MD, Ann Petlin, RN, MSN,
W. Claiborne Dunagan, MD, and Victoria J. Fraser, MD, St Louis, Mo
The development and implementation of a voluntary, nonpunitive, anonymous reporting
mechanism with causal coding for analyzing patient safety event descriptions is feasible and
facilitates local dissemination of important event-related information.
1144 Hyperglycemia during cardiopulmonary bypass is an independent risk
factor for mortality in patients undergoing cardiac surgery
Torsten Doenst, MD, PhD, Duminda Wijeysundera, MD, Keyvan Karkouti, MD,
Christoph Zechner, MD, Manjula Maganti, MSc, Vivek Rao, MD, PhD, and
Michael A. Borger, MD, PhD, Toronto, Ontario, Canada, and Freiburg, Germany
The influence of hyperglycemia during cardiopulmonary bypass (CPB) on outcome was
assessed in 6290 patients undergoing cardiac surgery (1999-2001). High peak glucose during
CPB was an independent predictor of mortality in both diabetic (odds ratio [OR], 1.20; 95%
confidence interval [95% CI], 1.08-1.32) and nondiabetic (OR, 1.12; 95% CI, 1.06-1.19; per
millimole per liter increase in glucose) patients.
1151 Cardioplegia prevents ischemia-induced transcriptional alterations of
cytoprotective genes in rat hearts: A DNA microarray study
Steve J. Schomisch, BS, Deborah G. Murdock, PhD, Nasim Hedayati, MD,
Joseph L. Carino, BS, Edward J. Lesnefsky, MD, and Brian L. Cmolik, MD,
Cleveland, Ohio, and Nashville, Tenn
Differences in gene expression profiles after ischemia versus cardioplegia-protected ischemia
were evaluated by using DNA microarray technology in isolated rat hearts. Cardioplegia
preserved baseline transcription levels of genes involved in cytoprotective pathways, which
were otherwise diminished by ischemia. This novel concept might lead to improved myocardial
protective strategies for cardiac surgery.
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Cardiothoracic
Transplantation
(TX)
1159 High level of cerebral microembolization in patients supported with the
DeBakey left ventricular assist device
Nils H. Thoennissen, MD, Michael Schneider, MD, Achim Allroggen, MD, Martin Ritter, MD,
Ralf Dittrich, MD, Christof Schmid, MD, Hans H. Scheld, MD, E. Bernd Ringelstein, MD, and
Darius G. Nabavi, MD, Mu¨nster, Germany
In patients with the DeBakey LVAD, the predictive value of microembolic signals (MES) was
prospectively investigated. MES were detected in 20 (87%) patients with mean MES numbers
of 81.2  443 per hour. Through oronasal oxygen delivery (6 L/min), MES activity
significantly declined, indicating cavitation processes. No correlation of MES with clinical and
hemostaseologic parameters were found.
1167 Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully
allogeneic cardiac grafts and generates CD4 regulatory cells
Takeshi Yokoyama, MD, Osamu Aramaki, MD, Tadatoshi Takayama, MD, Seigo Takano, MD,
Qi Zhang, MSc, Motohide Shimazu, MD, Masaki Kitajima, MD, FACS,
Yoshifumi Ikeda, MD, FACS, Nozomu Shirasugi, MD, and
Masanori Niimi, MD, PhD, FACS, Tokyo, Japan
Single administration of the selective cyclooxygenase 2 inhibitor NS-398 induces indefinite
survival of fully allogeneic cardiac grafts in mice. It also protects allografts from rejection and
generates CD4 regulatory cells through increased production of interleukin 4 and interleukin
10.
1175 Persistently increased systemic, but not cardiac-specific, adhesion molecule
expression and coronary endothelial dysfunction in human cardiac allografts
Stephen M. Wildhirt, MD, PhD, Costas Schulze, MD, Nicole Conrad, PhD,
Robert Bauernschmitt, MD, Ru¨diger Lange, MD, and Wolfgang von Scheidt, MD,
Munich, Germany
Persistently high levels of soluble adhesion molecules (ICAM 1, P-selectin) in human cardiac
transplant recipients are of systemic and not cardiac-specific origin. They are associated with
impaired coronary vasomotor function during the first year after heart transplantation. They
may be early markers and mediators of transplant coronary artery disease.
1183 Role of the -adrenergic receptor kinase in myocardial dysfunction after
brain death
Prakash K. Pandalai, MD, Jefferson M. Lyons, MD, Jodie Y. Duffy, PhD,
Kelly M. McLean, MD, Connie J. Wagner, BS, Walter H. Merrill, MD, Jeffrey M. Pearl, MD,
and Shahab A. Akhter, MD, Cincinnati, Ohio
The primary mechanism of impaired -adrenergic receptor signaling with subsequent
ventricular dysfunction after brain death is increased activity of the -adrenergic receptor
kinase. This leads to desensitization of agonist-occupied -adrenergic receptors. Inhibition of
myocardial -adrenergic receptor desensitization after brain death might lead to an expanded
donor organ population.
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Clinical-Pathologic
Conference
1190 Clinical-pathologic conference in general thoracic surgery: Malignant
transformation of recurrent respiratory papillomatosis
Benjamin D. Kozower, MD, Cylen Javiden-Nejad, MD, James S. Lewis, MD,
Shabbir Safdar, MD, Joel D. Cooper, MD, and G. Alexander Patterson, MD, St Louis, Mo
Historical Perspectives 1194 Historical Perspectives of The American Association for Thoracic Surgery:
George J. Heuer, MD (1882-1950)
Robert B. Wallace, MD, McLean, Va
Brief Communications e1 Main pulmonary artery to innominate artery shunt during hybrid palliation
of hypoplastic left heart syndrome
Christopher A. Caldarone, MD, Lee N. Benson, MD, Helen Holtby, MD,
and Glen S. Van Arsdell, MD, Toronto, Ontario, Canada
e3 Extensive atrial wall resection in a patient with symptomatic idiopathic right
atrial enlargement
Dante Picarelli, MD, Alejandro Dodera, MD, Serrana Antunez, MD, Guillermo Touyá, MD,
and Diego Abdala, MD, Montevideo, Uruguay
1196 Diagnosis of ruptured pulmonary hydatid cyst by means of flexible
fiberoptic bronchoscopy: A report of three cases
Abdul Salam Yaseen Taha, MB, ChB, FICMS, Kurdistan, Iraq
1198 Clear cell carcinoma of the lung revisited
Juan C. Garzon, MD, Fernand M. Lai, MD, Tony S. K. Mok, MD, Anthony V. Manlulu, MD,
Calvin S. H. Ng, MD, Tak Wai Lee, MD, and Anthony P. C. Yim, MD, Hong Kong SAR, China
1199 Successful enucleation of a giant cardiac hemangioendothelioma showing an
unusual proliferation pattern
Hideki Kitamura, MD, Hitoshi Okabayashi, MD, PhD, Michiya Hanyu, MD, PhD,
Yoshiharu Soga, MD, PhD, Takuya Nomoto, MD, PhD, Hiroyuki Johno, MD,
Jota Nakano, MD, Takehiko Matsuo, MD, Tadaaki Yokota, MD, PhD, and
Katsumi Inoue, MD, PhD, Fukuoka, Japan
1201 Lymphangiomatous hamartoma: Cause or bystander of the isolated
chylopericardium?
Charalambos Zisis, MD, PhD, Dimitra Rontogianni, MD, PhD, Eliana Charalambous, MD,
and Ion Bellenis, MD, PhD, Athens and Crete, Greece
1203 Transcatheter closure of patent ductus arteriosus with the Inoue single-
branched stent graft
Naritatsu Saito, MD, Takeshi Kimura, MD, Masanao Toma, MD, Kazunari Sasaki, MD,
Toru Kita, MD, Masato Imura, MD, Toshihiko Saga, MD, and Kanji Inoue, MD,
Kyoto and Osaka, Japan
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1205 Induction chemotherapy, surgical resection, and high-dose chemotherapy for
mediastinal nonseminomatous germ-cell tumor
Hiroshi Date, MD, Katsuyuki Kiura, MD, Hiroshi Ueoka, MD, Masahiro Tabata, MD,
Katsuyuki Hotta, MD, Hideki Katayama, MD, Itaru Kataoka, MD, and Mitsune Tanimoto, MD,
Okayama, Japan
1207 One-stage definitive repair of pulmonary atresia with intact ventricular
septum and hypoplastic right ventricle
Takeshi Shinkawa, MD, Masaaki Yamagishi, MD, Keisuke Shuntoh, MD, Keitarou Koushi, MD,
Takahiro Hisaoka, MD, and Hitoshi Yaku, MD, Kyoto, Japan
1208 The “clover technique” as a new approach for correction of postendocarditic
severe tricuspid valve regurgitation
Georges Fayad, MD, Thomas Modine, MD, Pierre-Vladimir Ennezat, MD,
Thierry Le Tourneau, MD, PhD, Benoît Larrue, MD, Richard Azzaoui, MD,
Olivier Nugue, MD, Olivier Leroy, MD, Christophe Decoene, MD, Philippe Asseman, MD, and
Henri Warembourg, MD, Lille and Tourcoing, France
1210 Left main coronary artery atresia masquerading as dilated cardiomyopathy
treated with aortic reimplantation
Ying-Jui Lin, MD, Chi-Di Liang, MD, Sheung-Fat Ko, MD, Chien-Fu Huang, MD, and
Jen-Ping Chang, MD, Kaohsiung and Taoyuan, Taiwan
1212 Separation of thoracopagus-cardiopagus twins joined by a myocardial
bridge
Louis C. Benjamin, MD, Jai Nahar, MD, Craig Sable, MD, Frank M. Midgley, MD, and
Gregory B. Di Russo, MD, Pittsburgh, Pa, and Washington, DC
1213 Thoracoscopic removal of a knife impaled in the chest
Joshua H. Burack, MD, Emmanuel A. Amulraj, MD, Patricia O’Neill, MD,
Gregory Brevetti, MD, and Robert C. Lowery, MD, Brooklyn, NY
1215 Aortic valve–sparing operation for autograft failure after the Ross
procedure
Aschraf El-Essawi, MD, Jochen Sänger, MD, Stefan Ulrich, MD, Ingo Kutschka, MD, and
Wolfgang Harringer, MD, Braunschweig, Germany
1216 A giant pleural fibrous tumor
Heyman Luckraz, FRCS, Saima Ehsan, MBBS, Allen R. Gibbs, FRCPath,
and Eric G. Butchart, FRCS, Cardiff, United Kingdom
1218 Left-sided modified Kergin carinoplasty as an alternative to carinal resection
for centrally located non–small cell lung cancer pretreated by
radiochemotherapy
Edgardo Pezzetta, MD, Antoine Meyer, MD, Ziad El Lamaa, MD, Lennart Magnusson, MD,
Marcel Kraft, MD, and Hans-Beat Ris, MD, Lausanne, Switzerland
1219 Thoracoscopic operation with local and epidural anesthesia in the treatment
of pneumothorax after lung transplantation
Seiichiro Sugimoto, MD, Hiroshi Date, MD, Ryujiro Sugimoto, MD, Megumi Okazaki, RN,
Motoi Aoe, MD, Yoshifumi Sano, MD, and Nobuyoshi Shimizu, MD, Okayama, Japan
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1221 Chronic dissection of the right aortic sinus with detachment of the aortic
annulus and coronary artery
Jain Bhaskara Pillai, MD, Tirone E. David, MD, and Annette Vegas, MD, Toronto, Ontario,
Canada
1222 Emergency surgical intervention in a patient with delayed diagnosis of aortic
dissection presenting with acute ischemic stroke and undergoing
thrombolytic therapy
Chai-Hock Chua, MD, Li-Ming Lien, MD, Chia-Hsun Lin, MD, and Chi-Ren Hung, MD,
Taipei, Taiwan
1224 Combined surgical and endoprothesical approach to solve a thoracic aortic
pseudoaneurysm 15 years after coarctation correction
Ramiro de la Llana, MD, Rafael Martínez-Sanz, MD, Francisco Díaz-Romero, MD,
Ibrahim Nassar, MD, and Pilar Garrido, MD, Tenerife, Spain
Letters to the Editor 1226 Evaluation of surgical trauma and cardiopulmonary bypass as factors in
inflammatory status after cardiac surgery
Elsayed M. Elmistekawy, MD, Tabuk, Saudi Arabia
1226 Reply
R. Prondzinsky and K. Werdan, Halle/Saale, Germany
1227 Radial artery for coronary artery bypass grafting
Sergio V. Moran, MD, Santiago, Chile
1227 Reply
Shafi Mussa, MA, MRCS, Bikram P. Choudhary, MRCS, and
David P. Taggart, MD(Hons), PhD, FRCS, Oxford, United Kingdom
Events of Interest 1229 Events
Announcements The American Association for Thoracic Surgery
1231 Announcement of 2006 Annual Meeting
1232 The American Association for Thoracic Surgery Disclosure Statement
The Western Thoracic Surgical Association
1233 Announcement of 2006 Annual Meeting
The American Board of Thoracic Surgery
1233 Notices
1234 Requirements for Recertification/Maintenance of Certification
Table of Contents (continued)
(continued on page 30A)
28A The Journal of Thoracic and Cardiovascular Surgery ● October 2005
ED
ITO
RIA
L
G
TS
A
CD
CH
D
ET
CSP
TX
Notices of Correction 1195 Correction of article by Nilto C. De Oliveira, MD, Rekwan Sittiwangkul, MD,
Brian W. McCrindle, MD, MPH, Anne Dipchand, MD, Tae-Jin Yun, MD, John
G. Coles, MD, Christopher Caldarone, MD, William G. Williams, MD, and Glen
S. Van Arsdell, MD, titled “Biventricular repair in children with atrioventricular
septal defects and a small right ventricle: Anatomic and surgical considerations”
(2005;130:250-7)
1195 Correction of article by Harold M. Burkhart, MD, David A. Ashburn, MD, Igor
E. Konstantinov, MD, PhD, Nilto C. De Oliviera, MD, Lee Benson, MD, William
G. Williams, MD, and Glen S. Van Arsdell, MD, titled “Interdigitating arch
reconstruction eliminates recurrent coarctation after the Norwood procedure”
(2005;130:61-5)
1195 Correction of article by Philip E. Bernatz, MD, titled “Historical Perspectives
of The American Association for Thoracic Surgery: Stuart Harrington, MD
(1889-1975)” (2005;129:670-1)
Reader Services 38A Information for Authors
44A Information for Readers
46A Copyright Transmittal Form
1061 Change of address
Online article or online article component
Table of Contents (continued)
30A The Journal of Thoracic and Cardiovascular Surgery ● October 2005
ED
ITO
RIA
L
G
TS
A
CD
CH
D
ET
CSP
TX
